BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16866795)

  • 1. Hormones down under: hormone therapy use after the Women's Health Initiative.
    Travers C; O'Neill SM; Khoo SK; King R
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):330-5. PubMed ID: 16866795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing use of hormone therapy among minority women since the Women's Health Initiative.
    Helenius IM; Korenstein D; Halm EA
    Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in hormone therapy use before and after publication of the Women's Health Initiative trial: 10 years of follow-up.
    Barbaglia G; Macià F; Comas M; Sala M; del Mar Vernet M; Casamitjana M; Castells X
    Menopause; 2009; 16(5):1061-4. PubMed ID: 19369903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
    Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
    Gerend MA; Aiken LS; Erchull MJ; Lapin A
    Prev Med; 2006 Sep; 43(3):158-64. PubMed ID: 16750263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy use among postmenopausal French women before the publication of the Women's Health Initiative study: duration of use and factors associated with discontinuation.
    Ringa V; Varnoux N; Piault S; Bréart G
    Fertil Steril; 2005 Jun; 83(6):1771-9. PubMed ID: 15950650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status.
    Travers C; O'Neill SM; King R; Battistutta D; Khoo SK
    Climacteric; 2005 Mar; 8(1):56-62. PubMed ID: 15804732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
    Levine DW; Dailey ME; Rockhill B; Tipping D; Naughton MJ; Shumaker SA
    Psychosom Med; 2005; 67(1):98-104. PubMed ID: 15673630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
    Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
    Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.
    Lazar F; Costa-Paiva L; Morais SS; Pedro AO; Pinto-Neto AM
    Maturitas; 2007 Feb; 56(2):129-41. PubMed ID: 16901660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study.
    Lindh-Astrand L; Brynhildsen J; Hoffman M; Hammar M
    Menopause; 2009; 16(6):1213-7. PubMed ID: 19455070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.
    Rigby AJ; Ma J; Stafford RS
    Menopause; 2007; 14(5):853-8. PubMed ID: 17429334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.